These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1722791)

  • 1. The pathophysiology of benign prostatic hyperplasia.
    McConnell JD
    J Androl; 1991; 12(6):356-63. PubMed ID: 1722791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of clinical benign prostatic hyperplasia.
    Shapiro E; Lepor H
    Urol Clin North Am; 1995 May; 22(2):285-90. PubMed ID: 7539174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
    Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age related urodynamic changes in patients with benign prostatic hyperplasia.
    Madersbacher S; Klingler HC; Schatzl G; Stulnig T; Schmidbauer CP; Marberger M
    J Urol; 1996 Nov; 156(5):1662-7. PubMed ID: 8863566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
    Bushman W
    Urol Clin North Am; 2009 Nov; 36(4):403-15, v. PubMed ID: 19942041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of symptoms in patients with benign prostatic hyperplasia].
    Riehmann M; Jønler M; Nordling J; Hald T
    Ugeskr Laeger; 1996 May; 158(20):2853-8. PubMed ID: 8686021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of growth factors in benign prostatic hyperplasia.
    Lawson RK
    Eur Urol; 1997; 32 Suppl 1():22-7. PubMed ID: 9218939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia. Hormonal treatment.
    McConnell JD
    Urol Clin North Am; 1995 May; 22(2):387-400. PubMed ID: 7539183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic hyperplasia.
    Jonler M; Riehmann M; Brinkmann R; Bruskewitz RC
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):795-807. PubMed ID: 7535688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment.
    Hellstrom WJ; Giuliano F; Rosen RC
    Urology; 2009 Jul; 74(1):15-21. PubMed ID: 19428091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.